October 2, 2024
WASHINGTON, DC — Radiation oncologists can feel confident offering hypofractionated treatment regimens to treat breast cancer in patients who are planning breast reconstruction after mastectomy, following […]
October 2, 2024
Share on PinterestWhether through food or supplements, there are healthy ways to get more iron in your diet without relying on red meat. Clarkand Company/Getty Images […]
October 2, 2024
Share on PinterestFor weeks, Son Vang (center) thought his persistent cough was a lingering flu symptom. Then, a chest x-ray revealed he was experiencing heart failure. […]
October 1, 2024
On This Page Date: October 10, 2024 Time: 8:15 AM – 5:30 PM ET Location: Event Location FDA HeadquartersFDA headquarters in White Oak, MD 10903 New […]
October 1, 2024
FDA is aware of the devastating impact Hurricane Helene had to Baxter International’s North Cove manufacturing facility in Marion, North Carolina. Our thoughts go out to […]
October 1, 2024
The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved […]
October 1, 2024
Issued by: Guidance Issuing Office Human Foods Program Office of Inspections and Investigations Center for Devices and Radiological Health Center for Drug Evaluation and Research BACKGROUND: […]
October 1, 2024
For Immediate Release: October 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
October 1, 2024
Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
Docket Number: FDA-2008-D-0610 Issued by: Guidance Issuing Office Human Foods Program Center for Biologics Evaluation and Research Center for Devices and Radiological Health Center for Drug […]